Microbial metabolite-guided CAR T cell engineering enhances anti-tumor immunity via epigenetic-metabolic crosstalk.
Staudt S, Nikolka F, Perl M, Franz J, Leblay N, Yuan XK, Warmuth L, Fantes MA, Skorupskaitė A, Fei T, Bromberg M, Martin-Uriz PS, Rodriguez-Madoz JR, Ziegler-Martin K, Gholam NA, Benz P, Tran PH, Freitag F, Riester Z, Stein-Thoeringer C, Schmitt M, Kleigrewe K, Weber J, Mangold K, Einsele H, Prosper F, Ellmeier W, Busch D, Visekruna A, Slingerland J, Shouval R, Hiller K, van den Brink M, Pausch P, Neri P, Hudecek M, Poeck H, Luu M.
Staudt S, et al. Among authors: leblay n.
bioRxiv [Preprint]. 2024 Sep 13:2024.08.19.608538. doi: 10.1101/2024.08.19.608538.
bioRxiv. 2024.
PMID: 39314273
Free PMC article.
Preprint.